Founded in Switzerland in 1896, it is a well-known brand in the field of global diabetes care and the world's leading R&D-based health company

Roche Diagnostics is committed to developing and providing innovative, cost-effective, timely and reliable diagnostic systems and solutions from early detection and prevention of diseases to diagnosis and monitoring, so as to help medical staff improve patient outcomes, improve people's quality of life, and reduce social healthcare costs.

Roche is uniquely positioned as the only innovation leader in the medical industry covering diagnostics and pharmaceuticals. This combination allows us to apply breakthrough disease knowledge to develop innovative products, discover and monitor diseases, and guide treatment options.

In August 2000, Roche Diagnostic Products (Shanghai) Co., Ltd. was established as a wholly foreign-owned company in Shanghai Waigaoqiao Free Trade Zone to carry out business in Chinese mainland.

Since its establishment, the company has grown its business and scale, and is a leader in the in vitro diagnostics market in China. So far, the company has more than 2,000 employees, distributed in more than 70 cities across the country. Headquartered in Shanghai, the company has branches in Beijing, Guangzhou, Nanjing, Hangzhou and Jinan.

The company's product sales and service network all over the country, with its first-class technical products, with perfect service has won a wide range of market and reputation. Roche Diagnostics has a strong commitment to the Chinese market, and will make outstanding contributions to China's medical and health undertakings and the improvement of people's quality of life by improving testing efficiency and medical value.